Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Topical rapamycin improves TSC facial lesions.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- Author(s): KUZNAR, WAYNE
- Source:
Dermatology Times. Sep2018, Vol. 39 Issue 9, p38-38. 1p.
- Additional Information
- Subject Terms:
- Abstract:
The article focuses on data from a randomized placebo-controlled study reported by Dr. Mary Kay Koenig and colleagues in the journal "JAMA Dermatology" which showed that topical rapamycin improved facial angiofibromas secondary to tuberous sclerosis complex. Topics discussed include treatments for facial angiofibromas, the first improvement in lesions with the use of rapamycin according to Dr. Koenig, and adverse events that were believed to be treatment related.
No Comments.